Kristen Hege

Insider Reports History

Location
500 Forbes Blvd, South San Francisco, CA
Signature
/s/ Alejandra Carvajal, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristen Hege:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Adaptimmune Therapeutics PLC Director Option to purchase Ordinary Shares 660K Jul 1, 2024 Direct
Mersana Therapeutics, Inc. Director Stock Option (right to buy) 61.5K Jun 12, 2025 Direct
Graphite Bio, Inc. Director Stock Option (right to buy) 20K Jul 19, 2023 Direct

Insider Reports Filed by Kristen Hege

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRSN Mersana Therapeutics, Inc. Jun 12, 2025 1 $0 4 Jun 13, 2025 Director
ADAP Adaptimmune Therapeutics PLC Jul 1, 2024 1 $0 4 Jul 1, 2024 Director
MRSN Mersana Therapeutics, Inc. Jun 11, 2024 1 $0 4 Jun 12, 2024 Director
ADAP Adaptimmune Therapeutics PLC Jan 15, 2024 1 $0 4 Jan 17, 2024 Director
MRSN Mersana Therapeutics, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 Director
ADAP Adaptimmune Therapeutics PLC Nov 1, 2023 0 $0 3 Nov 1, 2023 Director
MRSN Mersana Therapeutics, Inc. Oct 2, 2023 1 $0 4 Oct 4, 2023 Director
GRPH Graphite Bio, Inc. Jul 19, 2023 1 $0 4 Jul 21, 2023 Director
MRSN Mersana Therapeutics, Inc. Jul 3, 2023 1 $0 4 Jul 6, 2023 Director
MRSN Mersana Therapeutics, Inc. Jun 8, 2023 2 $0 4 Jun 12, 2023 Director
MRSN Mersana Therapeutics, Inc. Apr 3, 2023 1 $0 4 Apr 5, 2023 Director
GRPH Graphite Bio, Inc. Jun 21, 2022 1 $0 4 Jun 22, 2022 Director
MRSN Mersana Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
MRSN Mersana Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
GRPH Graphite Bio, Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 Director
MRSN Mersana Therapeutics, Inc. Jun 11, 2021 1 $0 4 Jun 15, 2021 Director